204 related articles for article (PubMed ID: 31646553)
1. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
Guan X; Xu Y; Zheng J
Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
[TBL] [Abstract][Full Text] [Related]
5. PCAT6 participates in the development of gastric cancer through endogenously competition with microRNA-30.
Xu Y; Sun JY; Jin YF; Yu H
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5206-5213. PubMed ID: 30178843
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt.
Zhai XQ; Meng FM; Hu SF; Sun P; Xu W
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1969-1977. PubMed ID: 30915739
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
[TBL] [Abstract][Full Text] [Related]
13. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.
Wang J; Xu W; He Y; Xia Q; Liu S
Inflamm Res; 2018 Dec; 67(11-12):927-936. PubMed ID: 30310931
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer.
Yang XS; Wang GX; Luo L
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):616-622. PubMed ID: 29461589
[TBL] [Abstract][Full Text] [Related]
19. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
Lai XJ; Cheng HF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
